Literature DB >> 10961570

The use of a medical dictionary for regulatory activities terminology (MedDRA) in prescription-event monitoring in Japan (J-PEM).

M Yokotsuka1, M Aoyama, K Kubota.   

Abstract

The Medical Dictionary for Regulatory Activities Terminology (MedDRA) version 2.1 (V2.1) was released in March 1999 accompanied by the MedDRA/J V2.1J specifically for Japanese users. In prescription-event monitoring in Japan (J-PEM), we have employed the MedDRA/J for data entry, signal generation and event listing. In J-PEM, the lowest level terms (LLTs) in the MedDRA/J are used in data entry because the richness of LLTs is judged to be advantageous. A signal is generated normally at the preferred term (PT) level, but it has been found that various reporters describe the same event using descriptions that are potentially encoded by LLTs under different PTs. In addition, some PTs are considered too specific to generate the proper signal. In the system used in J-PEM, when an LLT is selected as a candidate to encode an event, another LLT under a different PT, if any, is displayed on the computer screen so that it may be coded instead of, or in addition to, the candidate LLT. The five-level structure of the MedDRA is used when listing events but some modification is required to generate a functional event list.

Mesh:

Year:  2000        PMID: 10961570     DOI: 10.1016/s1386-5056(00)00062-9

Source DB:  PubMed          Journal:  Int J Med Inform        ISSN: 1386-5056            Impact factor:   4.046


  7 in total

1.  A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database.

Authors:  M Lindquist; M Ståhl; A Bate; I R Edwards; R H Meyboom
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

2.  Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions.

Authors:  Cédric Bousquet; Georges Lagier; Agnès Lillo-Le Louët; Christine Le Beller; Alain Venot; Marie-Christine Jaulent
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Comparison of losartan with ACE inhibitors and dihydropyridine calcium channel antagonists: a pilot study of prescription-event monitoring in Japan.

Authors:  Kazuo Samizo; Eri Kawabe; Shiro Hinotsu; Tsugumichi Sato; Shigeru Kageyama; Chikuma Hamada; Yasuo Ohashi; Kiyoshi Kubota
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Prescription-event monitoring in Japan (J-PEM).

Authors:  Kiyoshi Kubota
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  A case report: using SNOMED CT for grouping Adverse Drug Reactions Terms.

Authors:  Iulian Alecu; Cedric Bousquet; Marie-Christine Jaulent
Journal:  BMC Med Inform Decis Mak       Date:  2008-10-27       Impact factor: 2.796

6.  A knowledge graph of clinical trials ([Formula: see text]).

Authors:  Ziqi Chen; Bo Peng; Vassilis N Ioannidis; Mufei Li; George Karypis; Xia Ning
Journal:  Sci Rep       Date:  2022-03-18       Impact factor: 4.379

7.  Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study.

Authors:  Izumi Sato; Manabu Akazawa
Journal:  Drug Healthc Patient Saf       Date:  2013-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.